ARA 290 5MG
Firstly, ARA 290, aka cibinetide, is an 11–amino acid peptide that are entirely derived from the helix beta domain of Erythropoietin (EPO). Above all, has potent tissue-protective and tissue-regenerative properties. Secondly, it exerts its beneficial effects without stimulating erythropoesis or red blood cell production.
Moreover, ARA 290 peptide has demonstrated the ability to reduce HbA1c and improve cholesterol. Despite it all, it has yet to receive FDA approval since results remain in the trial stages. The peptide has reached Phase II clinical trials for several neuropathic conditions, above all, pain management. Nevertheless, clinical research is very promising and offers hope for a natural alternative for pain management.
How ARA 290 works:
In short, it mediates tissue protection by selectively interacting with the innate repair receptor. To clarify, this stimulates tissue repair and decreases inflammation and apoptosis (programmed cell death) as seen in preclinical and clinical studies.
- Pain Management
- Reduces Inflammation
- Promotes Healing & Wound Repair
- Restores Nerve Damage
- Reduces Symptoms of Diabetes
Molecular Formula: C51H84N16O21
Molecular Mass: 1257.3 g/mol
THIS PRODUCT IS FOR RESEARCH ONLY
This designation allows the use of research chemicals and peptides strictly for in vitro testing and research, to be handled by qualified and licensed professionals, in laboratory settings only. Bodily introduction or injection of any kind, into humans or animals, is strictly illegal by law. This product is NOT for human use and can be harmful if ingested. This product is not in a sterile solution. It is not a drug, food, or cosmetic.
Please read our Terms and Conditions prior to ordering.